Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Vallvé JC, Ferré R, Heras M, Rodríguez-Calvo R, Guaita-Esteruelas S, Martínez-Micaelo N, Plana N, Masana L.

J Clin Med. 2019 Oct 26;8(11). pii: E1793. doi: 10.3390/jcm8111793.

2.

Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.

Parra S, Heras M, Herrero P, Amigó N, Garcés E, Girona J, Correig X, Canela N, Castro A.

Rheumatology (Oxford). 2019 Aug 23. pii: kez293. doi: 10.1093/rheumatology/kez293. [Epub ahead of print]

PMID:
31504936
3.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.

4.

Plasma glucose, triglycerides, VLDL, leptin and resistin levels as potential biomarkers for myocardial fat in mice.

Rodríguez-Calvo R, Samino S, Guaita-Esteruelas S, Martínez-Micaelo N, Heras M, Girona J, Yanes O, Correig X, Masana L.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30064-6. doi: 10.1016/j.arteri.2019.05.001. [Epub ahead of print] English, Spanish.

PMID:
31221535
5.

Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.

Rodríguez-Calvo R, Girona J, Rodríguez M, Samino S, Barroso E, de Gonzalo-Calvo D, Guaita-Esteruelas S, Heras M, van der Meer RW, Lamb HJ, Yanes O, Correig X, Llorente-Cortés V, Vázquez-Carrera M, Masana L.

Metabolism. 2019 Jul;96:12-21. doi: 10.1016/j.metabol.2019.04.007. Epub 2019 Apr 15.

PMID:
30999003
6.

FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.

Bosquet A, Girona J, Guaita-Esteruelas S, Heras M, Saavedra-García P, Martínez-Micaelo N, Masana L, Rodríguez-Calvo R.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jun;1863(6):604-613. doi: 10.1016/j.bbalip.2018.03.004. Epub 2018 Mar 15.

PMID:
29550588
7.

Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.

Masana L, Girona J, Ibarretxe D, Rodríguez-Calvo R, Rosales R, Vallvé JC, Rodríguez-Borjabad C, Guardiola M, Rodríguez M, Guaita-Esteruelas S, Oliva I, Martínez-Micaelo N, Heras M, Ferré R, Ribalta J, Plana N.

J Clin Lipidol. 2018 Mar - Apr;12(2):292-299.e3. doi: 10.1016/j.jacl.2017.12.018. Epub 2018 Jan 8. Review.

PMID:
29398429
8.

LipSpin: A New Bioinformatics Tool for Quantitative 1H NMR Lipid Profiling.

Barrilero R, Gil M, Amigó N, Dias CB, Wood LG, Garg ML, Ribalta J, Heras M, Vinaixa M, Correig X.

Anal Chem. 2018 Feb 6;90(3):2031-2040. doi: 10.1021/acs.analchem.7b04148. Epub 2018 Jan 17.

PMID:
29293319
9.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
10.

Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.

Guaita-Esteruelas S, Saavedra-García P, Bosquet A, Borràs J, Girona J, Amiliano K, Rodríguez-Balada M, Heras M, Masana L, Gumà J.

Oncologist. 2017 Nov;22(11):1309-1315. doi: 10.1634/theoncologist.2016-0483. Epub 2017 Jul 12.

11.

Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.

Girona J, Ibarretxe D, Plana N, Guaita-Esteruelas S, Amigo N, Heras M, Masana L.

Cardiovasc Diabetol. 2016 Aug 4;15(1):107. doi: 10.1186/s12933-016-0428-z.

12.

Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.

Bosquet A, Guaita-Esteruelas S, Saavedra P, Rodríguez-Calvo R, Heras M, Girona J, Masana L.

Atherosclerosis. 2016 Jun;249:191-9. doi: 10.1016/j.atherosclerosis.2016.04.012. Epub 2016 Apr 14.

PMID:
27155388
13.

Letter to Editor: Increased Presence of Remnant Lipoprotein Cholesterol in The Hdl of Diabetic Subjects.

Gonzàlez M, Heras M, Rosales R, Guardiola M, Plana N, Vallvé JC, Masana L, Ribalta J.

Ann Clin Lab Sci. 2016 Spring;46(2):229-32. No abstract available.

PMID:
27098636
14.

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Ibarretxe D, Girona J, Amigó N, Plana N, Ferré R, Guaita S, Mallol R, Heras M, Masana L.

J Clin Lipidol. 2016 Mar-Apr;10(2):330-8.e2. doi: 10.1016/j.jacl.2015.12.012. Epub 2015 Dec 22.

PMID:
27055964
15.

Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.

Amigó N, Mallol R, Heras M, Martínez-Hervás S, Blanco Vaca F, Escolà-Gil JC, Plana N, Yanes Ó, Masana L, Correig X.

Sci Rep. 2016 Jan 18;6:19249. doi: 10.1038/srep19249.

16.

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.

Ibarretxe D, Girona J, Plana N, Cabré A, Ferré R, Amigó N, Guaita S, Mallol R, Heras M, Masana L.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):71-8. doi: 10.1016/j.arteri.2015.11.001. Epub 2015 Dec 29.

PMID:
26743379
17.

Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men.

Guardiola M, Solà R, Vallvé JC, Girona J, Godàs G, Heras M, Gonzàlez M, Rock E, Winklhoffer-Roob BM, Masana L, Ribalta J.

J Clin Lipidol. 2015 Nov-Dec;9(6):824-831.e1. doi: 10.1016/j.jacl.2015.08.001. Epub 2015 Aug 7.

PMID:
26687704
18.

New insights into circulating FABP4: Interaction with cytokeratin 1 on endothelial cell membranes.

Saavedra P, Girona J, Bosquet A, Guaita S, Canela N, Aragonès G, Heras M, Masana L.

Biochim Biophys Acta. 2015 Nov;1853(11 Pt A):2966-74. doi: 10.1016/j.bbamcr.2015.09.002. Epub 2015 Sep 4.

19.

Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.

Samino S, Vinaixa M, Díaz M, Beltran A, Rodríguez MA, Mallol R, Heras M, Cabre A, Garcia L, Canela N, de Zegher F, Correig X, Ibáñez L, Yanes O.

Sci Rep. 2015 Jun 23;5:11496. doi: 10.1038/srep11496.

20.

Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy.

Mallol R, Amigó N, Rodríguez MA, Heras M, Vinaixa M, Plana N, Rock E, Ribalta J, Yanes O, Masana L, Correig X.

J Lipid Res. 2015 Mar;56(3):737-46. doi: 10.1194/jlr.D050120. Epub 2015 Jan 7.

Supplemental Content

Loading ...
Support Center